We recently reported that ectopic expression of Ell3 stabilizes p53 in an ER(+) breast cancer cell line by activating the expression of interleukin 20 (IL-20), leading to chemosensitization of MCF7 cells upon CDDP treatment [6]. Here, ELL3 is linked to breast cancer.